Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KIKKOMAN, Apr-Dec (Cumulative 3Q) Net Income Increases by 13%
2801 KIKKOMAN CORPORATION 【IFRS】
Earnings ReportKIKKOMAN CORPORATION <2801> [TSE Prime] announced its financial results (based on IFRS) after the market closed on February 5th (15:30). The consolidated net income for the cumulative third quarter of the fiscal year ending March 2025 (April to December) increased 12.8% from the same period last year, reaching 51.3 billion yen. The progress rate toward the full-year plan of 61.5 billion yen was 83.5%, almost the same as the four-year average of 83.2%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net income for the January to March period (4Q) is expected to decrease 6.9% from the same period last year to 10.1 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated net income amounted to 16.5 billion yen, a 0.8% decrease compared to the same period last year. The operating profit margin decreased from 11.5% in the same period last year to 11.4%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 466,363 | 46,322 | 50,640 | 36,375 | 38.0 | 83.3 | Feb 3, 2023 | IFRS |
Apr - Dec, 2023 | 494,875 | 53,345 | 60,654 | 45,521 | 47.7 | 80.2 | Feb 5, 2024 | IFRS |
Apr - Dec, 2024 | 535,515 | 62,480 | 70,059 | 51,329 | 54.0 | 83.3 | Feb 5, 2025 | IFRS |
YoY | +8.2% | +17.1% | +15.5% | +12.8% | +13.1% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 338,102 | 33,249 | 37,751 | 27,632 | 29.0 | 14 | Apr 26, 2024 | IFRS |
Oct - Mar, 2024 Guidance | 340,131 | 32,603 | 36,756 | 26,745 | 28.4 | 11 | Nov 6, 2024 | IFRS |
YoY | +0.6% | -1.9% | -2.6% | -3.2% | -2.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 618,899 | 55,370 | 60,797 | 43,733 | 45.7 | 15.60 | Apr 27, 2023 | IFRS |
Mar, 2024 | 660,835 | 66,733 | 75,605 | 56,441 | 59.2 | 20.80 | Apr 26, 2024 | IFRS |
Mar, 2025 Guidance | 695,700 | 74,600 | 84,100 | 61,500 | 65.3 | 21 | Nov 6, 2024 | IFRS |
YoY | +5.3% | +11.8% | +11.2% | +9.0% | +10.2% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 172,142 | 19,861 | 22,800 | 16,712 | 17.5 | 11.5 | Feb 5, 2024 | IFRS |
Jan - Mar, 2024 | 165,960 | 13,388 | 14,951 | 10,920 | 11.5 | 8.1 | Apr 26, 2024 | IFRS |
Apr - Jun, 2024 | 178,218 | 21,474 | 24,675 | 18,046 | 19.0 | 12.0 | Aug 5, 2024 | IFRS |
Jul - Sep, 2024 | 177,351 | 20,523 | 22,669 | 16,709 | 17.6 | 11.6 | Nov 6, 2024 | IFRS |
Oct - Dec, 2024 | 179,946 | 20,483 | 22,715 | 16,574 | 17.4 | 11.4 | Feb 5, 2025 | IFRS |
YoY | +4.5% | +3.1% | -0.4% | -0.8% | -0.5% |
Related Articles
ICHINEN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 27%, Oct-Dec Ordinary Profit Increases by 7%
Soken Chemical & Engineering, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 61%, Oct-Dec Ordinary Profit Increases by 5%
CUBE SYSTEM, The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 18% Decrease
J-LEASE, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 26%, Oct-Dec Ordinary Profit Increases by 22%
Concordia Financial, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 67%
KYORIN Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 30%, Oct-Dec Ordinary Profit Decreases by 55%
FUJI KYUKO, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 7%
Noevir, Oct-Dec (1Q) Ordinary Profit Decreases by 8%
NIHON KOHDEN, Oct-Dec (3Q) Ordinary Profit Increases by 16 times
TOBU RAILWAY, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 2%